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ABSTRACT
Current recommendations within integrated community case management (iCCM) programmes 
advise community health workers (CHWs) to refer cases of chest indrawing pneumonia to health 
facilities for treatment, but many children die due to delays or non-compliance with referral 
advice. Recent revision of World Health Organization (WHO) pneumonia guidelines and inte-
grated management of childhood illness chart booklet recommend oral amoxicillin for treatment 
of lower chest indrawing (LCI) pneumonia on an outpatient basis. However, these guidelines did 
not recommend its use by CHWs as part of iCCM, due to insufficient evidence regarding safety.
We present a protocol for a one-arm safety intervention study aimed at increasing access to 
treatment of pneumonia by training CHWs, locally referred to as Community Oriented 
Resource Persons (CORPs) in Nigeria. The primary objective was to assess if CORPs could 
safely and appropriately manage LCI pneumonia in 2–59 month old children, and refer 
children with danger signs. The primary outcomes were the proportion of children 
2–59 months with LCI pneumonia who were managed appropriately by CORPs and the 
clinical treatment failure within 6 days of LCI pneumonia. Secondary outcomes included 
proportion of children with LCI followed up by CORPs on day 3; caregiver adherence to 
treatment for chest indrawing, acceptability and satisfaction of both CORP and caregivers on 
the mode of treatment, including caregiver adherence to treatment; and clinical relapse of 
pneumonia between day 7 to 14 among children whose signs of pneumonia disappeared 
by day 6. Approximately 308 children 2–59 months of age with LCI pneumonia would be 
needed for this safety intervention study.
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Background
Considerable progress has been made globally in the 
reduction of under-five mortality [1]. However, mor-
tality remains high with 5.4 million deaths of children 
under 5 years old reported in 2017, of which 73% 
occurred across sub-Saharan Africa and Southeast 
Asia [1]. Pneumonia was a leading cause of these 
deaths, with an estimated 0.9 million pneumonia- 
related deaths in children aged 2–59 months in 
2015; again over 75% of these deaths were in sub- 
Saharan Africa and Southeast Asia [2]. It is also 
a leading cause of death in Nigeria, accounting for 
140,520 deaths in children under 5 years old in 
2016 [3].
Mothers and other caregivers have an important 
role in early recognition of symptoms and in seeking 
immediate appropriate care for the sick child [4]. 
However, care seeking for pneumonia from an appro-
priate provider (accredited by the government) varies 
largely; from 27.2% in Ethiopia, 39.7% in Nigeria to 
78.9% in Uganda [5]. Despite this, for children with 
signs of pneumonia, including chest indrawing for 
whom referral is indicated, many do not reach the 
referral facilities due to geographical, financial and 
socio-cultural barriers [6,7].
While recognising the important role of formal 
public and private health-care systems in service pro-
vision, current evidence suggests the need for a rapid 
expansion of access to low-cost, high-impact child 
health services at community-level to tackle common 
causes of child mortality [8–10]. Measures to improve 
care seeking for pneumonia by caregivers and appro-
priate training, support and supervision of commu-
nity health workers (CHWs) can help reduce 
pneumonia-related mortality among children. These 
measures include enabling the CHWs to correctly 
assess, classify and manage fast breathing and chest 
indrawing pneumonia using oral antibiotic and coun-
selling of caregivers on early care seeking [11,12]. 
A number of existing federal and state-level pro-
grammes in Nigeria provide community-level access 
to child health services, but often focus on single 
illnesses, lack effective linkages to formal, facility- 
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based health services, and high coverage to have 
a sustained impact.
In April 2013, the Nigeria Federal Ministry of 
Health (FMoH) approved the national policy on inte-
grated community case management (iCCM). The 
approach effectively extends the curative aspect of 
Integrated Management of Childhood Illness (IMCI) 
to the community level for the management of child-
hood malaria, pneumonia and diarrhoea. It is equity 
focused and is designed to provide prompt and effec-
tive case management of malaria, pneumonia and 
diarrhoea for children 2–59 months old in their com-
munities. In addition, iCCM is expected to expand 
the scope, and improve effectiveness and integration 
with other community-based programmes such as 
health promotion. In Nigeria, iCCM services are pro-
vided by a designated community member known as 
a Community Orientated Resource Person (CORP), 
who are selected from and by their own communities 
to receive training as iCCM providers. They are sup-
ported through the provision of commodities and by 
supervising health facilities. Community sensitisation 
and mobilisation are also components of iCCM in 
Nigeria, to promote high levels of uptake by care-
givers of children [13]. At the time of the study 
(2016–2018), the CORPs were providing iCCM ser-
vices on a voluntary basis as per national guidelines.
The safety and efficacy of managing chest indraw-
ing pneumonia with oral amoxicillin among children 
2–59 months of age have been previously demon-
strated at community level in Pakistan and Kenya 
[14–16]. These studies observed a lower need for 
referral or hospitalisation, and lower associated 
household and treatment costs [17]. It is postulated 
that community management of chest indrawing 
pneumonia would reduce transport, food and lost 
income costs for families; reduce pressure on already 
overburdened hospitals; and reduce risk of hospital- 
acquired infections. In 2012, the World Health 
Organization (WHO) revised its guidelines for the 
classification and treatment of childhood pneumonia 
for outpatient and inpatient hospital treatment [18]. 
WHO recommended oral amoxicillin for treatment 
of chest indrawing pneumonia on an outpatient basis 
at health facility level. It did not recommend its use 
by CHWs as part of iCCM, because there was still 
a lack of evidence about the safety of treating chest 
indrawing pneumonia in children at community level 
and the ability of CHWs to monitor their status to 
ascertain clinical deterioration and need for referral 
[19]. In 2016, data were unavailable from Africa on 
CHW management of chest indrawing pneumonia 
using oral amoxicillin in children 2–59 months of 
age, with the exception of the study in Kenya which 
was yet unpublished. To address this gap, a one-arm 
safety intervention study was conducted to assess the 
feasibility and capacity of CHWs in Nigeria to 
manage chest indrawing pneumonia in young chil-
dren, instead of the current practice of referring such 
children to health facilities for management.
During the course of development of the study 
protocol including a customised study mobile app, 
and during data collection, considerable time was 
required for adaptation and refinement to adequately 
respond to the complexity of the topic. This was 
particularly in relation to ensuring the safety of the 
enrolled children and as a result, a unique study 
design and protocol were created which could serve 
as a prototype for similar studies. This paper presents 
the protocol for this study and will be used as 
a means to reference the underlying methodology in 
more detail within the result paper.
Methods
Study aim and objectives
The objective of this one-arm safety intervention 
study was to establish whether CHWs in Nigeria 
can safely manage chest indrawing pneumonia in 
2–59 month old children with oral amoxicillin as 
part of an iCCM programme. A secondary objective 
was to assess the acceptability and satisfaction of such 
an approach among the CHWs as providers and the 
caregivers of children who were included.
Study design
This one-arm safety intervention study was carried 
out in two local government areas (LGAs), Paikoro 
and Lapai in Niger state.
Study site
Niger State, located in Nigeria’s North Central Zone, 
geographically the largest of the country’s states, has 
a population spread across rural areas with just 30% 
in urban areas. Children under 5 years make up 21% 
of the population, which is made up of Muslims, 
Christians and a small minority practising traditional 
beliefs. Under the WHO supported Rapid Access 
Expansion (RAcE) project, Malaria Consortium col-
laborated with the FMoH to establish and strengthen 
an iCCM programme in six LGAs in the state in 
2013. The total population of these six LGAs was 
1,245,939 of whom approximately 249,200 were chil-
dren aged 2–59 months. The expected incidence of 
clinical pneumonia in this area in Nigeria was 0.28/ 
child/year with an estimated 12% progressing to 
severe disease [20]. This study was conducted in 
two LGAs where the CORPs had been delivering 
iCCM services for at least 2 years before the start of 
the study – namely Lapai and Paikoro (Figure 1) with 
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an approximate population of 164,000 and 222,200, 
respectively.
The selected LGAs had 356 CORPs (187 in Lapai 
and 169 in Paikoro) who had received a 6-day train-
ing on iCCM and had been equipped to provide these 
services for 2 years prior to the study. The objectives 
of the training were to build the capacity of the 
CORPs to detect and treat fast breathing pneumonia 
and diarrhoea and to diagnose and treat malaria with 
rapid diagnostic tests and artemisinin-based combi-
nation therapy, respectively. The training course was 
based on the WHO/UNICEF training programme 
‘Caring for the sick child in the community’ and 
incorporated an integrated approach where the 
CORPs were trained to holistically assess the child 
and perform a differential diagnosis of their condi-
tion [21]. They were taught to recognise and refer 
cases with danger signs such as chest indrawing, give 
pre-referral treatment and refer as well as assess the 
nutritional and immunisation status of children 
under five.
Study participants
A total of 356 CORPs across the two LGAs received 
additional training to be involved in the study. All 
children 2–59 months of age with possible chest 
indrawing but no danger signs (persistent vomiting, 
lethargic/unconscious, convulsions, not able to drink/ 
breastfeed) were eligible for enrolment in the study. 
All sick infants younger than 2 months were referred 
to the supporting health facility. All children who 
were brought to CHWs in the two LGAs to receive 
care as part of iCCM services were potentially eligible 
to be included in the study. Caregivers of children 
who were classified as having chest indrawing pneu-
monia were given the option of having their child 
included in the study and thereby receiving treatment 
at home instead of being referred to a health facility 
as per the national iCCM guidelines.
Intervention description
Sensitisation
Sensitisation meetings to introduce the study were 
organized at state and LGA levels. At state level, the 
main aim was to create awareness and increase the 
chances that research findings would inform imple-
mentation guidelines by programme implementers 
and policy-makers. At LGA level, consensus dialo-
gues were organised for government staff, members 
of parliament and village chiefs. Support from com-
munity leaders was sought for disseminating mes-
sages to their respective communities, and to 
motivate households to seek care from the CORPs. 
Community mobilisation activities such as consulta-
tive meetings with community and religious leaders, 
as well as local announcements, were also organised 
at LGA and community levels. Through the RAcE 
project, there was already a strategy of community 
engagement which included community dialogues, 
which were community-led, with the CORP and 
community leader as facilitators. These meetings sti-
mulated beneficial health-related decision making in 
the community. During the course of the study, the 
CORPs used this forum to share further the design 
and purpose of the study, answered community con-
cerns and promoted community support and 
engagement.
Figure 1. Nigeria map on left with Niger state marked, on right Niger state with two LGAs for chest indrawing pneumonia study.
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Training
All trainings were designed by a capacity building 
specialist who directly trained the study team on 
how to train others on the study procedures. This 
team then conducted a 2-day training of 12 clinically 
trained research assistants (RA), who were a mix of 
community health extension workers and nurses, all 
of whom had also received training on iCCM. The 
RAs, in turn, conducted 3-day training courses for 
CORPS who were already trained in iCCM. These 
trainings included practical sessions for the CORPs 
to practise assessment of chest indrawing (using 
videos and visits to local hospital to see real cases), 
recruitment of children into the study including 
informed consent from caregivers and study protocol 
forms and steps. The study team also trained the 
supervisors from the reference health facilities that 
were supporting the CORPs in the LGAs where the 
study took place. As quality control measures, all 
trainings of the CORPs and their supervisors 
included pre- and post-tests, a training report com-
pleted by the trainers, and observations of trainings 
were conducted by the study team.
As a safety measure, RAs were also trained on 
a modified version of the WHO/UNICEF IMCI tool 
for their re-assessment of children to ensure no child 
was put at additional danger by being enrolled in the 
study. This training included the use of pulse oximetry 
as an extra precaution to ensure that enrolled children 
did not need referral for hypoxemia. The pulse oximeter 
given to the RAs was a Masimo iSpO2 Pulse Oximeter 
with micro USB connector for android devices with 
Masimo iSpO2 M_LNCS DCIP Pediatric Digit Sensor 
and Masimo LNCS YI Multisite Reusable Sensor with 
foam wrap for infants. The RAs’ main tasks were to 
confirm CORPs’ chest indrawing classification of chil-
dren 2–59 months of age after recruitment and to 
collect data on primary and secondary outcomes during 
the follow-up visits. The RAs also assessed the child for 
any other illnesses, danger signs or other indications for 
referral. If detected, they gave advice and referred when 
required. Caregivers were also instructed to continue 
with the full antibiotic course as prescribed by the 
CORP to avoid the development of resistance, regard-
less of the result of the re-assessment by the RA or the 
health facility worker, even if they were diagnosed as 
not having chest indrawing pneumonia. If the child was 
referred to a health facility, to provide a history for the 
health staff receiving the child, the RA completed 
a form indicating clearly the results of their assessment, 
the reasons for referral and detailing the course of 
amoxicillin the child had been prescribed.
Identification of eligible children by CORPs
There were two stages for the identification and 
inclusion of eligible children into the study, as the 
RA had to confirm the CORP’s initial assessment 
before the child was fully included in the study. 
These stages are distinguished here by the use of the 
terms ‘recruitment’ for the CORP and ‘enrolment’ by 
the RA. The first stage with the CORP was the 
recruitment of the child into the study, which also 
included the giving of informed consent by the care-
giver, and the allocation of a Unique Identifier Code 
(UIC) to the child by the CORP. The second stage 
was after the RA had completed their re-assessment 
of the child and they then enrolled the child into the 
study.
CORPs identified patients through passive surveil-
lance and through periodic community outreach 
activities. Based on epidemiological data, it was 
expected that over a 12 month period of study data 
collection, each CORP would recruit 1–2 children 
with chest indrawing pneumonia. CORPs assessed 
all sick children presenting using the sick child 
assessment form and managed eligible children 
according to study protocol.
Consent and recruitment by CORPs on day 0
The CORPs recruited any eligible children on the 
consent of the caregiver. The CORPs gave literate 
caregivers the opportunity to read the consent form 
in full or read aloud to them if requested, explaining 
every aspect of the consent form to the caregiver, and 
answering any questions before the form was signed, 
or a thumbprint given, in triplicate by both the care-
giver and the CORP. The CORP assigned a UIC to 
the child at this point.
In total, the CORPs conducted three different 
types of recruitment on day 0 as shown in Figure 2 
and detailed below.
a. Study recruitment:
All children 2-59 months of age with chest 
indrawing but without other danger signs were 
considered eligible for study recruitment and con-
sent obtained from the primary caregiver. The 
CORP gave the first dose of dispersible oral amox-
icillin and observed the child for 30 minutes. If the 
child did not vomit s/he was considered recruited 
into the study. If the child vomited the first dose of 
amoxicillin, a repeat dose of oral amoxicillin was 
given and the child was excluded from the study if 
they vomited this also. The CORP provided the 
caregiver of the recruited child with dispersible 
amoxicillin tablets for 5 days according to the 
child’s age group (Table 1). The CORP provided 
any other treatments for malaria or diarrhoea if 
required and scheduled follow-up visits for day 0 
(<12 hrs), 3, 6 and 15 with the caregiver of 
recruited child. The CORP then called the RA to 
notify them of the recruitment.
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b. Referral recruitment:
All children 2–59 months with chest indrawing 
whose caregivers signed the consent form and who 
were subsequently referred were also followed up by 
the RA on day 0. The RA then followed up the 
referred child within 1 day after recruitment by the 
CORP, recording information regarding the child’s 
outcome in a tablet application. These children were 
included in the study as their data were necessary for 
the analysis of the primary outcome on the ability of 
CORPs to appropriately manage children with chest 
indrawing pneumonia. 
c. Quality assurance recruitment:
As a quality assurance measure, once a CORP had 
enrolled a child with chest indrawing pneumonia, 
they were instructed to follow the study recruitment 
procedures for the next child they saw with fast 
breathing but without chest indrawing or danger 
signs. The purpose of this quality assurance recruit-
ment was to assess their ability to correctly classify 
the absence of chest indrawing in children with 
suspected pneumonia. These children were provided 
standard iCCM care and treatment and were then re- 
assessed by the RA within 12 hours. No further data 
were collected on them.
Study enrolment by research assistants on day 0-1
The RA visited the recruited child within the follow-
ing 12 hours to independently assess them using 
a tablet-based mobile data collection application, 
built on CommCare version 2.29.1 (Dimagi, Inc. 
Cambridge, MA, USA). The application also required 
the RAs to check if the child had received any other 
treatments in relation to their illness prior to present-
ing to the CORP, a factor included in the final ana-
lysis of treatment outcome. Eligible children were 
then included as enrolments by the RA on the appli-
cation. If a child was found to have danger signs or 
hypoxaemia (SpO2 < 90%), or any other illness that 
was not treated by the CORP, the RA facilitated 
referral to the nearest health facility and the child 
was excluded from the study. If the RA did not detect 
chest indrawing and the caregiver indicated that there 
had been no history of chest indrawing, the RA 
Figure 2. CORP recruitment: different types on day 0.
Table 1. Dosing instructions for dispersible amoxicillin [19].
Age group Weight Dose recommendation Total daily dose
2 to 11 months 4 to <10 kg 1 tab 2 times a day x 5 days 500 mg
12 to 35 months 10 to <14 kg 2 tabs 2 times a day x 5 days 1000 mg
36 to 59 months 14 to <19 kg 3 tabs 2 times a day x 5 days 1500 mg
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assessed the CORP’s ability to identify chest indraw-
ing pneumonia using videos of chest indrawing on 
the RA’s tablet. If the CORP passed this assessment, 
the child was then enrolled by the RA into the study.
Follow-up visit by CORPs on day 3
If the child was not brought by the caregiver on day 3 
as per standard iCCM guidelines, the CORPs visited 
them at home. This was to ensure that there was no 
deterioration in the child’s condition and if necessary, 
to refer the child to a health facility. The CORP re- 
assessed the child, recorded the findings in a study 
form, and enquired if the caregiver provided the 
amoxicillin tablets according to the instructions 
given.
Follow-up visits by RAs on day 6 and day 15
On the 6th and 15th day after enrolment, the RA 
together with the CORP visited the enrolled children 
to re-assess them according to the IMCI protocol and 
interview the caregivers using the study data collec-
tion form on the tablet CommCare application. 
Questions included current health status, adherence 
to treatment (using pill count), care providers visited 
after visiting the CORP, alternative treatments given, 
and hospitalisation, if any reported by the caregiver. 
Clinical relapse of pneumonia (defined in Table 3) 
was determined based on the child’s clinical condi-
tion assessed on day 15.
The specific activities taking place for each of the 
follow-up visits can be found in Table 2. If on any of 
the follow-up days, enrolled children could not be 
found at home, the CORP/RA made two more 
attempts to follow up with the caregiver to trace the 
child. The study coordinator visited all the treatment 
failures for re-assessment of the child within 1 day of 
being notified by the RA, who would know of this 
through their own assessment or from the CORP 
almost immediately.
Quality assurance verification
During the study, to monitor the quality of the CORP’s 
classification of chest indrawing, a proportion of chil-
dren who were brought to the CORP and classified as 
having fast breathing pneumonia were followed up by 
the RA and re-assessed following iCCM guidelines 
(Quality Assurance recruitments).
Sample size
Sample size for a prevalence survey with finite popula-
tion correction was calculated in STATA 13 (STATA 
Corp, College Station, TX, USA). Assuming that the 
proportion of treatment failure was 50% (using the 
most conservative estimate) a sample size of 196 chil-
dren was needed to calculate the overall proportion of 
children with chest indrawing pneumonia who experi-
enced treatment failure by day 6 with ±7% precision at 
95% confidence level. Assuming a design effect of 1.3 
to account for clustering of CORP performance in case 
more than one child is enrolled by one CORP [22], the 
total sample size required was 255 children; this was 
inflated to 308 to account for potential losses to follow- 
up including 10% non-response rate for caregivers and 
10% erroneous enrolments.
Outcomes
The primary outcomes measured were
(I) Proportion of children under 5 years classi-
fied with chest indrawing pneumonia who 
were managed appropriately by CORPs.
(II) Clinical treatment failure of chest indrawing 
pneumonia by day 6.
Secondary outcomes:
(I) Proportion of children under 5 years classi-
fied with chest indrawing who were followed 
up by the CORPs on day 3.
(II) Clinical relapse of pneumonia between day 7 
to 14 among children under 5 years whose 
signs of pneumonia disappeared by day 6.
(III) Acceptability and satisfaction with commu-
nity management of chest indrawing pneu-
monia among CORPs and caregivers.
Table 3 an outline of study procedures including 
outcome assessment.
Table 2. Follow-up visit schedule for children enrolled.
Day 0 0–1 3 6 15
Activity Screening and 
enrolment
Re-assessment Re-assessment Re-assessment Re-assessment
Person CORP RA CORP CORP & RA RA
Outcomes -CORP performance to classify & manage chest 
indrawing 
-Health status
-Health status -Health status 
- Treatment failure 
-Treatment 
adherence
-Health status 
-Clinical relapse
Location CORP Household CORP or 
Household
Household Household
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Data collection tools
To facilitate timely and complete data collection, as 
well as supporting quality assurance of CORP perfor-
mance, an electronic data collection application was 
developed in CommCare for the study which was 
loaded onto electronic tablets (Tecno™ 7 C). This 
application was designed as a job aid for the RAs 
and also as a guided data entry process into electronic 
study forms and included different electronic forms 
for each stage of enrolment and follow-up of enrolled 
children. The application guided them through the 
WHO/UNICEF IMCI tool adapted for the study to 
verify the eligibility of the children recruited by the 
CORPs. This assessment included the use of 
a handheld pulse oximeter to check their oxygen 
saturation level and to confirm the medication and 
dosages prescribed. Each RA was provided with 
a locally available tablet on which the study 
CommCare app had been loaded, along with videos 
of chest indrawing, which were used as reference 
during assessment visits and for refresher training 
of the CORPs.
Data management
A system for regular monitoring was established to 
ensure that study activities were implemented as per 
plan, using approved standard operating proce-
dures. Each week, the Research Coordinator down-
loaded the data from the CommCare server and 
pasted it into an Excel-based data checker, which 
was used to highlight any duplicate entries, correct 
data entry mistakes reported by the RAs and to 
monitor progress on enrolment. The data checker 
was circulated to the study team on a weekly basis. 
The data manager regularly reviewed all data sub-
missions for enrolled children, including study 
forms uploaded by RAs on day 0–1, 6 and 15, as 
well as follow-up forms submitted by CORPs on day 
3. These submissions, which were anonymised from 
recruitment through the use of the UIC, were 
checked for completeness and accuracy. This UIC 
was also used to store the case data in a project 
database. While all data collection forms had inbuilt 
consistency and range checks, any additional discre-
pancies identified were raised during supervision 
visits.
Qualitative component
The aim of the qualitative component of the study 
was to assess CORPs’ acceptability and caregiver 
acceptability and satisfaction with community-level 
management of chest indrawing pneumonia. This 
component was included in recognition of the impor-
tance of human behaviour and attitudes whenever Ta
bl
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3.
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introducing any new intervention, and this mix of 
qualitative and quantitative methodology is increas-
ingly being adopted in clinical trials [23]. It involved 
conducting individual semi-structured interviews 
with CORPs on day 6 – this being their final day of 
follow-up of a child enrolled with chest indrawing. 
For the caregivers, the individual interviews were 
conducted with them on day 15 after the final day 
of follow-up by the RA for children recruited with 
chest indrawing pneumonia. For each group, there 
was a questionnaire developed which was used as the 
topic guide for the interview with different questions 
for each group. Four RAs with no previous experi-
ence in qualitative data collection were selected based 
on their previously observed levels of competence 
and because they were fluent both in the local lan-
guage and in English. They were trained for 3 days by 
the study team on how to conduct and audio-record 
the interviews in the local language, and then trans-
late and transcribe the data. This included role plays 
and field testing of the tools with CORPs and care-
givers. Interviews were conducted until data satura-
tion was reached in both groups.
Data analysis
Main variables that were collected during the follow- 
up visits, using the study application on the RAs’ 
tablets included baseline characteristics of children 
and caregivers (children’s age and sex, caregivers’ 
age, sex, education, marital status, rural/urban resi-
dence). Clinical data for the children (both at recruit-
ment into the study and at follow-up visits) included 
health status and symptoms present (fever, respira-
tory rate, chest indrawing) and danger signs. 
Treatment and care seeking history after initial pre-
sentation to CORPs including any visit to other pro-
viders and secondary treatment with antimicrobial 
medicines prescribed – which should have been 
recorded as a treatment failure. Data were also col-
lected on adherence to the amoxicillin treatment 
schedule and any hospitalisation and mortality 
among the children.
The data were exported from the mobile data 
collection forms into Excel and then exported to 
STATA 13 for analysis. The primary analysis was 
conducted on the intention-to-treat population 
(including all children for whom the primary out-
come was collected). Pearson’s Chi-squared test was 
used to test for association between categorical data 
accounting for clustering using the svy command in 
STATA 13. The baseline characteristics of the chil-
dren and caregivers were summarised using descrip-
tive statistics with means (SD) and medians (IQR). 
Proportions of the primary outcomes (CORPs’ per-
formance, treatment failure) and secondary outcomes 
(adherence to follow-up, adherence to treatment, 
clinical relapse) were calculated and presented with 
95% confidence intervals (CI).
The qualitative data from the transcriptions were 
analysed following a thematic analysis using 
‘Framework Approach’ [24] using MAXQDA 
(VERBI Software, Berlin, Germany, 2016) to manage 
data coding, searching and retrieval. A sample of the 
transcriptions of recordings from local language into 
English was checked for accuracy in translation by 
the study team. Another sample of English transla-
tions was reviewed by the qualitative research specia-
list for data quality purposes (e.g. to check for 
sufficient probing and adherence to the topic guide). 
Summaries of each theme were reviewed and dis-
cussed by the study team before the final 
consolidation.
Quality assurance
Quality assurance (QA) exercises were conducted 
immediately after the initial training, 1 month after 
training and again 6 months after training. An 
experienced iCCM trainer was used as the reference 
standard evaluator and assessed a group of study staff 
(CORPs and RAs). The CORPs were shown at least 
two different videos of children with or without chest 
indrawing and any misclassification was considered 
to be an error.
At the early stages of the study, a Data and Safety 
Monitoring Board (DSMB) was established to review 
periodic reports from the study, as well as compliance 
with the study protocol. The DSMB worked as an 
independent body comprised five experts, who served 
in their individual capacity to provide an assessment 
of the project and its outcomes.
Discussion
This study had several strengths within its design 
which can allow it to serve as a model for evaluating 
the safety and acceptability of a new treatment inter-
vention at community level, within the context of an 
already functioning iCCM programme. A key 
requirement was that no child should be put at any 
additional risk by being enrolled in the study, while at 
the same time, the procedure for delivering the inter-
vention needed to be as close to real-life setting as 
possible. This was made possible by adding two com-
ponents to the study design – the RAs who verified 
the CORPs’ assessments and by the use of an electro-
nic data collection application which allowed data to 
be transmitted in near real-time. RAs were required 
to conduct verification visits within 12 hours of the 
child being seen by the CORP, and to conduct 
a comprehensive assessment based on IMCI guide-
lines, as would be expected if the child was seen in 
a health facility. Furthermore, the RAs were equipped 
GLOBAL HEALTH ACTION 9
with pulse oximeters to measure oxygen saturation so 
that any seriously hypoxaemic child (SpO2 < 90%) 
would be detected and immediately referred [25].
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